1Structural Biology Program, Department of Physiology & Biophysics, Mount Sinai School of Medicine, New York University, One Gustave Levy Place, New York, NY 10029, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
The promyelocytic leukemia protein (PML) binds eukaryotic initiation factor 4E (eIF4E), reducing its activity. This interaction inhibits oncogenic transformation by decreasing Cyclin D1 levels, revealing PML
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: